CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- 4 Open-market buy 10% owner bought 240,587 shares at an average $10.02 ($2,410,360)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.18 ($20,360)
- 4/A Grant or award Chief People Officer acquired 18,608 shares (grant or award)
- 4 Grant or award Chief People Officer acquired 18,608 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 1,400 shares at $11.88 ($16,632)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $11.64 ($23,280)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $12.06 ($24,120)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.97 ($21,940)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $10.87 ($21,740)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $10.98 ($109,800)
- 4 Open-market buy Director bought 20,000 shares at an average $10.76 ($215,248)
- 3/A Insider 3/A
- 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
- 4 Grant or award Director acquired 2,200 shares (grant or award)
- 4 Grant or award Director acquired 7,334 shares (grant or award)
- 4 Grant or award Director acquired 2,200 shares (grant or award)
- 4 Grant or award Director acquired 2,200 shares (grant or award)
Page 9 of 47 · 936 filings